Literature DB >> 24167702

Clozapine for self-injurious behavior in individuals with borderline personality disorder.

Theodore Zarzar1, Joseph McEvoy.   

Abstract

Prior reports suggest that clozapine can markedly reduce aggression and self-injurious behavior in patients with borderline personality disorder (BPD). We present a series of four patients with BPD and persistent self-injurious behavior treated with clozapine at a state psychiatric hospital. After treatment with clozapine these patients ceased self-injurious behaviors and aggression, and no longer required intensive levels of observation or restrictive procedures. All were successfully discharged from the hospital soon after initiation of clozapine. Clozapine appears to be efficacious in the management of chronic suicidality, self-injurious behaviors and aggression in patients with severe BPD.

Entities:  

Keywords:  Borderline personality disorder; aggression; clozapine; suicide

Year:  2013        PMID: 24167702      PMCID: PMC3805385          DOI: 10.1177/2045125313484323

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN: 2045-1253


  10 in total

1.  A 27-year follow-up of patients with borderline personality disorder.

Authors:  J Paris; H Zweig-Frank
Journal:  Compr Psychiatry       Date:  2001 Nov-Dec       Impact factor: 3.735

2.  Clozapine and borderline personality disorder.

Authors:  George F Parker
Journal:  Psychiatr Serv       Date:  2002-03       Impact factor: 3.084

3.  Clozapine treatment of a borderline personality disorder with severe self-mutilating behaviours.

Authors:  Mélanie M Ferreri; Mélanie M Ferrerri; Jean-Yves Loze; Frédéric Rouillon; Frédéric Limosin
Journal:  Eur Psychiatry       Date:  2004-05       Impact factor: 5.361

4.  Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.

Authors:  Menahem I Krakowski; Pal Czobor; Leslie Citrome; Nigel Bark; Thomas B Cooper
Journal:  Arch Gen Psychiatry       Date:  2006-06

5.  Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder.

Authors:  K N Chengappa; T Ebeling; J S Kang; J Levine; H Parepally
Journal:  J Clin Psychiatry       Date:  1999-07       Impact factor: 4.384

6.  Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder.

Authors:  F Benedetti; L Sforzini; C Colombo; C Maffei; E Smeraldi
Journal:  J Clin Psychiatry       Date:  1998-03       Impact factor: 4.384

Review 7.  Pharmacological interventions for borderline personality disorder.

Authors:  Jutta Stoffers; Birgit A Völlm; Gerta Rücker; Antje Timmer; Nick Huband; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2010-06-16

8.  Treatment of severe borderline personality disorder with clozapine.

Authors:  Adarsh Kumar Vohra
Journal:  Indian J Psychiatry       Date:  2010-07       Impact factor: 1.759

9.  Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

Authors:  Herbert Y Meltzer; Larry Alphs; Alan I Green; A Carlo Altamura; Ravi Anand; Alberto Bertoldi; Marc Bourgeois; Guy Chouinard; M Zahur Islam; John Kane; Ranga Krishnan; J P Lindenmayer; Steven Potkin
Journal:  Arch Gen Psychiatry       Date:  2003-01

10.  Clozapine treatment of borderline patients: a preliminary study.

Authors:  F R Frankenburg; M C Zanarini
Journal:  Compr Psychiatry       Date:  1993 Nov-Dec       Impact factor: 3.735

  10 in total
  3 in total

Review 1.  Continuing clozapine treatment with lithium in schizophrenic patients with neutropenia or leukopenia: brief review of literature with case reports.

Authors:  Memduha Aydin; Bilge Cetin Ilhan; Saliha Calisir; Seda Yildirim; Ibrahim Eren
Journal:  Ther Adv Psychopharmacol       Date:  2016-02

2.  Clozapine for Treatment-Refractory Aggressive Behavior.

Authors:  Teodorescu Andreea; Ifteni Petru; Ana Aliana Miron; Petric Paula-Simina; Dima Lorena
Journal:  Psychiatr Q       Date:  2020-09-12

3.  Use of Clozapine for Borderline Personality Disorder: A Case Report.

Authors:  Badii Amamou; Walid Bel Hadj Salah; Ahmed Mhalla; Nejla Benzarti; Hend Elloumi; Ferid Zaafrane; Lotfi Gaha
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-05-31       Impact factor: 2.582

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.